{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:35:31Z","timestamp":1791311731011,"version":"4.3.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["advancesinpediatrics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Pediatrics"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.yapd.2014.03.002","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T23:30:15Z","timestamp":1399073415000},"page":"225-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Advances in the Diagnosis and Treatment of Cystic Fibrosis"],"prefix":"10.1016","volume":"61","author":[{"given":"Stacey L.","family":"Martiniano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana E.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Sagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith T.","family":"Zemanick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yapd.2014.03.002_bib1","series-title":"The metabolic and molecular bases of inherited disease","first-page":"521","article-title":"Cystic fibrosis","author":"Welsh","year":"2001"},{"key":"10.1016\/j.yapd.2014.03.002_bib2","series-title":"Pediatric respiratory medicine","first-page":"845","article-title":"Cystic fibrosis: overview","author":"Anselmo","year":"2008"},{"key":"10.1016\/j.yapd.2014.03.002_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic fibrosis of the pancreas and its relation to celiac disease","volume":"56","author":"Andersen","year":"1938","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.yapd.2014.03.002_bib4","series-title":"Cystic Fibrosis Foundation patient registry: 2012 annual data report to the center directors","year":"2013"},{"key":"10.1016\/j.yapd.2014.03.002_bib5","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","article-title":"Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life","volume":"183","author":"Cohen-Cymberknoh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1164\/rccm.201204-0785PP","article-title":"Personalized medicine in cystic fibrosis: dawning of a new era","volume":"186","author":"Clancy","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib7","first-page":"1","article-title":"Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs","volume":"53","author":"Grosse","year":"2004","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.yapd.2014.03.002_bib8","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1542\/peds.2006-1993","article-title":"Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report","volume":"119","author":"Comeau","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.yapd.2014.03.002_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(98)70344-0","article-title":"The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel","volume":"132","author":"Rosenstein","year":"1998","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.yapd.2014.03.002_bib10","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.yapd.2014.03.002_bib11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM199109123251104","article-title":"Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations","volume":"325","author":"Hammond","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib12","series-title":"Sweat testing: sample collection and quantitative chloride analysis; approved guideline\u2014third edition. CLSI document C34-A3","author":"LeGrys","year":"2009"},{"key":"10.1016\/j.yapd.2014.03.002_bib13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199410133311503","article-title":"A\u00a0novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations","volume":"331","author":"Highsmith","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/GIM.0b013e31818e55a2","article-title":"Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders","volume":"10","author":"Moskowitz","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib15","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1378\/chest.10-2077","article-title":"Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment","volume":"139","author":"Rogan","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.yapd.2014.03.002_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12016-008-8083-0","article-title":"Atypical cystic fibrosis and CFTR-related diseases","volume":"35","author":"Paranjape","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.yapd.2014.03.002_bib17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/jmg.2009.067215","article-title":"The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening","volume":"46","author":"Thauvin-Robinet","year":"2009","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.yapd.2014.03.002_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.2010.05879.x","article-title":"Modifier genes in Mendelian disorders: the example of cystic fibrosis","volume":"1214","author":"Cutting","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yapd.2014.03.002_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.mpg.0000178439.64675.8d","article-title":"Gastrointestinal outcomes and confounders in cystic fibrosis","volume":"41","author":"Borowitz","year":"2005","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.yapd.2014.03.002_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000029497","article-title":"Genotype and phenotype in cystic fibrosis","volume":"67","author":"Zielenski","year":"2000","journal-title":"Respiration"},{"issue":"Suppl 1","key":"10.1016\/j.yapd.2014.03.002_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.prrv.2013.01.006","article-title":"CFTR2: how will it help care?","volume":"14","author":"Castellani","year":"2013","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.yapd.2014.03.002_bib22","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.jpeds.2009.09.003","article-title":"Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond","volume":"155","author":"Borowitz","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.yapd.2014.03.002_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1183\/09031936.00057512","article-title":"CFTR biomarkers: time for promotion to surrogate end-point","volume":"41","author":"De Boeck","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.yapd.2014.03.002_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/MCP.0b013e328358d533","article-title":"Benchmarking to improve the quality of cystic fibrosis care","volume":"18","author":"Schechter","year":"2012","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib25","first-page":"522","article-title":"Cystic fibrosis pulmonary guidelines: airway clearance therapies","volume":"54","author":"Flume","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.yapd.2014.03.002_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A\u00a0controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1164\/rccm.201109-1666OC","article-title":"Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study","volume":"185","author":"Aitken","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.yapd.2014.03.002_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.293.5.581","article-title":"Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis","volume":"293","author":"Li","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.yapd.2014.03.002_bib33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archpediatrics.2011.136","article-title":"Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis","volume":"165","author":"Treggiari","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group","volume":"340","author":"Ramsey","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1164\/rccm.200712-1804OC","article-title":"Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis","volume":"178","author":"McCoy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/thx.2006.060889","article-title":"Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis","volume":"62","author":"Goss","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.yapd.2014.03.002_bib38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0022-3476(95)70343-8","article-title":"A\u00a0multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group","volume":"126","author":"Eigen","year":"1995","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.yapd.2014.03.002_bib40","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199503303321303","article-title":"Effect of high-dose ibuprofen in patients with cystic fibrosis","volume":"332","author":"Konstan","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJM200003233421204","article-title":"Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis","volume":"342","author":"Lai","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jpeds.2007.04.009","article-title":"High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial","volume":"151","author":"Lands","year":"2007","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.yapd.2014.03.002_bib43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1164\/rccm.200307-959OC","article-title":"Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis","volume":"169","author":"Paul","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib44","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.yapd.2014.03.002_bib45","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.2010.563","article-title":"Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"303","author":"Saiman","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.yapd.2014.03.002_bib46","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.12-0628","article-title":"Effect of azithromycin on systemic markers of inflammation in cystic fibrosis patients uninfected with Pseudomonas aeruginosa","volume":"142","author":"Ratjen","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.yapd.2014.03.002_bib47","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib48","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A\u00a0CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib49","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201301-0153OC","article-title":"Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation","volume":"187","author":"Davies","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib50","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in\u00a0vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.yapd.2014.03.002_bib51","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm1197-1280","article-title":"Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line","volume":"3","author":"Bedwell","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(08)61168-X","article-title":"Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial","volume":"372","author":"Kerem","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.yapd.2014.03.002_bib53","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.201001-0137OC","article-title":"Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis","volume":"182","author":"Sermet-Gaudelus","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib54","first-page":"A193","article-title":"Results of the phase 3 study of ataluren in nonsense mutation cystic fibrosis (NMCF)","volume":"35","author":"Rowe","year":"2012","journal-title":"Pediatr Pulmonol Suppl"},{"issue":"4","key":"10.1016\/j.yapd.2014.03.002_bib55","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1165\/rcmb.2013-0282OC","article-title":"Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor","volume":"50","author":"Xue","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.yapd.2014.03.002_bib56","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MCP.0b013e32834b8bdb","article-title":"Cystic fibrosis lung transplantation","volume":"17","author":"Braun","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.yapd.2014.03.002_bib57","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.healun.2013.08.008","article-title":"The Registry of the International Society for Heart and Lung Transplantation: sixteenth official pediatric lung and heart-lung transplantation report\u20132013; focus theme: age","volume":"32","author":"Benden","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.yapd.2014.03.002_bib58","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.healun.2013.08.007","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report\u20132013; focus theme: age","volume":"32","author":"Yusen","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.yapd.2014.03.002_bib59","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.yapd.2014.03.002_bib60","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/jc.2011-3050","article-title":"An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation","volume":"97","author":"Tangpricha","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.yapd.2014.03.002_bib61","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz","year":"2009","journal-title":"J\u00a0Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.yapd.2014.03.002_bib62","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.yapd.2014.03.002_bib63","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"Suppl 3","key":"10.1016\/j.yapd.2014.03.002_bib64","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2013state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.yapd.2014.03.002_bib65","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ppul.21423","article-title":"Anxiety, depression, and life satisfaction in parents caring for children with cystic fibrosis","volume":"46","author":"Besier","year":"2011","journal-title":"Pediatr Pulmonol"}],"container-title":["Advances in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310114000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310114000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:09:17Z","timestamp":1758744557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065310114000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0065310114000036"],"URL":"https:\/\/doi.org\/10.1016\/j.yapd.2014.03.002","relation":{},"ISSN":["0065-3101"],"issn-type":[{"value":"0065-3101","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the Diagnosis and Treatment of Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Advances in Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yapd.2014.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}